Prognostic Value of ACVRL1 Expression in Metastatic Colorectal Cancer Patients Receiving First-line Chemotherapy With Bevacizumab: Results From the Triplet Plus Bevacizumab (TRIBE) Study
Title:
Prognostic Value of ACVRL1 Expression in Metastatic Colorectal Cancer Patients Receiving First-line Chemotherapy With Bevacizumab: Results From the Triplet Plus Bevacizumab (TRIBE) Study
Author:
Hanna, Diana L. Loupakis, Fotios Yang, Dongyun Cremolini, Chiara Schirripa, Marta Li, Meng Matsusaka, Satoshi Berger, Martin D. Miyamoto, Yuji Zhang, Wu Ning, Yan Antoniotti, Carlotta Salvatore, Lisa Moran, Miriana Zeger, Gary Astrow, Stephanie H. Falcone, Alfredo Lenz, Heinz-Josef